Trademark Overview
On Thursday, August 14, 2025, a trademark application was filed for NORDICCTX-III with the United States Patent and Trademark Office. The USPTO has given the NORDICCTX-III trademark a serial number of 79433974. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, June 17, 2026. This trademark is owned by Nordic Bioscience A/S. The NORDICCTX-III trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Diagnostic biomarker reagents for medical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity for medical use; diagnostic biomarker assays for medical use to quantify disease activity; diagnostic biomarker assays for medical use to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for use in disease detection, disease analysis and quantifying disease activity; diagnostic agents for medical use; diagnostic reagents for medical use; clinical diagnostic agents; clinical diagnostic reagents for medical use; diagnostic preparations, diagnostic substances and diagnostic materials for medical purposes; medical diagnostic test strips for testing samples for the presence of biomarkers; diagnostic preparations for medical purposes
Design and development of blood-based biomarker assays for the identification, quantification and analysis of disease activity; design and development of diagnostic biomarker reagents for medical purposes, for pharmaceutical purposes and for scientific purposes; design and development of biochemical and pharmaceutical assays and medical assays; design and development of biomarkers for individual use or combined for the tracking of tissue formation, development or tissue degradation; pharmaceutical and scientific research in the fields of biomarkers and the detection of biomarkers; medical research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; scientific research in the nature of conducting clinical trials for others; medical research, namely, analysis of pharmacodynamic da...
